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Abstract The hypothesis was investigated that the nitric oxide 
(NO) synthase intermediate, N%hydroxy-L-arginine (HOArg), is 
an arginase inhibitor in rabbit or rat alveolar macrophages. Ex- 
ogenously applied HOArg strongly inhibited the arginase activity 
present in these cells (ICs0 > 15 ItM), and attenuated L- 
[3Hlarginine transport (ICs0 -> 500 ~M) in rabbit alveolar mac- 
rophages. Moreover, up to 37 ~M HOArg were detected in the 
conditioned medium, but not in the lysate, of rat alveolar macro- 
phages exposed to bacterial ipopolysaccharide for 18 h. HOArg 
may thus be a potent endogenous arginase inhibitor in these cells 
which increases the availability of L-arginine for NO biosynthesis. 
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1. Introduction 
Following exposure to bacterial l ipopolysaccharide (LPS) 
and/or various cytokines, macrophages express the Ca2+-inde - 
pendent isoform of nitric oxide (NO) synthase [1]. These cells 
also contain substantial amounts of arginase, the expression of 
which may also be upregulated in response to LPS [2]. Provided 
that the K m values and total activities of NO synthase and 
arginase are comparable,  the two enzymes may compete for the 
endogenous c-arginine, the availabil ity of which would eventu- 
ally become rate-l imiting for the synthesis of NO or L-ornithine. 
Recently, the NO synthase intermediate [3], NC-hydroxy-e - 
arginine (HOArg), has been shown to be a potent inhibitor of 
liver arginase [4,5]. Since substantial amounts of this intermedi- 
ate appear to be l iberated from the active site of NO synthase 
[6,7], it is conceivable that HOArg  may act as an endogenous 
arginase inhibitor in NO-producing cells, such as macrophages. 
We have investigated this hypothesis by comparing the en- 
dogenous formation of HOArg in LPS-stimulated alveolar 
macrophages with the effects of this amino acid on the arginase 
activity present in these cells. 
2. Materials and methods 
2.1. Materials 
NG-Hydroxy-L-arginine (HOArg) was generously supplied by Glaxo 
Group Research Ltd. L-[2,3,4,5-3H]Arginine (2.0-2.2 TBq/mmol) and 
L-[U-14C]ornithine (10 GBq/mmol) were obtained from Amersham; L- 
[U-~4C]citrulline (2.2 GBq/mmol) from NEN-DuPont; N6-mono - 
methyl-L-arginine, mouse interferon-), (IIFN-y) and LPS (serotype 
0127:B08) from Sigma; and NC'-nitro-e-arginine from Serva. 
*Corresponding author. Fax: (49) (69) 6301 7668. 
2.2. Cell culture and experimental protocols 
Alveolar macrophages from Sprague Dawley rats (200 250 g) or 
mongrel rabbits (1.5-2.0 kg) of either sex were prepared by broncho- 
alveolar lavage essentially as previously described [8]. Cells (2.5 x 106l 
well) were seeded into 6-well plates containing DMEM/Ham's F-12 
medium (ICN Biomedicals) upplemented with 2 mM L-glutamine, 100 
units/ml penicillin, 100,ug/ml streptomycin, 5/lg/ml amphotericin B and 
5% fetal calf serum (FCS; Vitromex). Non-adherent cells were removed 
by exchanging the medium 4 times at 1 h intervals. Adherent cells 
consisting of -> 90% macrophages (May Grfinwald-Giemsa staining) 
with a viability of -> 95% (Trypan blue exclusion) were cultured for 
18 h in the absence or presence of LPS (10/zg/ml). The conditioned 
medium was removed and stored at -70°C prior to analysis by HPLC 
for the amino acid pattern and colourimetric determination of the 
concentration f nitrite (NO~) [8]. In some experiments, the cells were 
lysed by adding 4 vols. of ice-cold methanol for HPLC analysis of the 
intracellular amino acid content. 
In another series of experiments the cells were washed and incubated 
for 60 min at 37°C in 1 ml HEPES-modified Krebs solution, pH 7.4 
(composition in mM: NaC1 118.5, KC1 5.7, CaCI 2 1.25, MgC12 1.2, 
NaH2PO4 0.001, Na2EDTA 0.03, (+)ascorbic acid 0.06, HEPES 20.0, 
D-glucose 11.1), containing 37 kBq L-[3H]arginine (~20,uM). The super- 
natants were removed and stored at -70°C prior to HPLC ana- 
lysis. 
Arginine uptake by rabbit alveolar macrophages was measured after 
resuspension of 10 6 freshly isolated cells in 0.5 ml Krebs solution con- 
taining L-[3H]arginine (37 kBq,-20/zM). Incubations were terminated 
after 5 min by adding 1 ml ice-cold Krebs solution. The cells were 
washed, collected by centrifugation, lysed with 0.4 M HCIO 4 (0.5 ml), 
and the cell-associated radioactivity determined by using a liquid scin- 
tillation fl-counter. Values for non-specific uptake at 4°C were sub- 
tracted from those obtained at 37°C to calculate specific L-[3H]arginine 
uptake. 
2.3. HPLC analyses 
HPLC/fluorescence analysis of the concentration of L-citrulline, L- 
arginine and HOArg in the supernatant or lysate of LPS-stimulated 
macrophages was performed by pre-column derivatization with o-ph- 
thalaldehyde as previously described [10], except that the column 
(250 x 4.6 mm (i.d.) Ultra Techsphere ODS, HPLC Technology) was 
isocratically eluted with 10 mM KH2PO4, pH 5.851acetonitrile/metha- 
nol/tetrahydrofuran 79:10: 10:1 (v/v/v/v) at a flow rate of 1 ml/min. 
L-Arginine, e-citrulline and HOArg were eluted from the column with 
retention times of 20.5, 14.1 and 18.5 min, respectively. 
HPLC analysis of the concentration of radio-labelled L-arginine, 
L-citrulline and L-ornithine was performed by using a 250 x 4.6 mm 
(i.d.) Hypersil ODS column (Shadon) which was isocratically eluted 
with 0.1 M NaH2PO 4, pH 1.8 (containing 400 mg/1 octane sulfonic acid 
and 0.3 mM Na2EDTA and 6.25% (v/v) methanol) at a flow rate of 
1 ml/min. The radioactivity of the eluate (1 ml fractions) was monitored 
by using a liquid scintillation fl-counter, and the retention times of the 
amino acids determined by comparison with those of authentic 
e-[3H]arginine (60 min), L-[U-~4C]ornithine (16 min) and L - [U-14C]c i t  - 
rulline (8 min). 
2.4. Statistical analysis 
Unless indicated otherwise, all data in the figures and text are ex- 
pressed as means + S.E.M. ofn observations. Statistical evaluation was 
performed by one way analysis of variance followed by a Bonferroni 
t-test for multiple comparisons with a P value < 0.05 considered statis- 
tically significant. 
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3. Results 
3.1. HOArg synthesis by LPS-stimulated macrophages 
Exposure of rat alveolar macrophages to LPS for 18 h re- 
sulted in a -12-fold increase in the concentration f NO2 and 
L-citrulline in the conditioned medium (Fig. 1) which was par- 
alleled by a comparable decrease in the level of L-arginine (to 
12% of the level in the supernatant of control cells). HOArg 
levels were also markedly elevated (to 7.5 36.9 ¢tM, average 
21.1 + 4.8 tiM), the concentration of which accounted for 
6.1 + 0.9% of the L-arginine consumed by the macrophage NO 
synthase (n -- 16). Interestingly, HOArg was not detectable in
lysates of LPS-treated rat alveolar macrophages, whereas both 
the intracellular nd extracellular concentration f L-citrulline 
were elevated to the same extent (not shown). Treatment of the 
cells with the NO synthase inhibitor, N%monomethyl-e-argin- 
ine (100 ¢tM), significantly attenuated the LPS-induced increase 
in the concentration f NO~ and L-citrulline (by 66% and 82%, 
respectively), but did not reduce the level of HOArg (Fig. 1). 
NO synthase inhibition also restored the level of L-arginine to 
79% of the concentration i  the supernatant of control cells. 
LPS-treatment of rabbit alveolar macrophages did not lead 
to a substantial increase in inducible NO synthase activity, since 
the level of NO~, e-citrulline and HOArg (Fig. 1, insert) in the 
conditioned medium was increased only by ~50% as compared 
to the supernatant of control cells. Co-incubation with N% 
nitro-L-arginine (100 /.tM), another NO synthase inhibitor, 
completely prevented the increase in HOArg. 
3.2. Arginase inhibition by HOArg 
Rabbit alveolar macrophages xposed to L-[3H]arginine for 
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Fig. 1. Generation of HOArg by LPS-stimulated alveolar macrophages. 
Rat or rabbit (insert) alveolar macrophages were incubated in culture 
medium in the absence (open columns) or presence (hatched columns) 
of LPS for 18 h, with or without 100/aM NG-monomethyl-L-arginine 
(filled columns) or NG-nitro-L-arginine (+ NNA). Thereafter the con- 
centration of nitrite (NOD, L-arginine (Arg), L-citrulline (Cit) and 
HOArg was determined in the conditioned medium (n = 34; *P < 0.05 





Fig. 2. Effects of LPS on arginase activity. Rabbit or rat alveolar 
macrophages were cultured for 18 h in the absence (open columns, 
n = 13-24) or presence (hatched columns, n= 13 37) of LPS, with or 
without NG-monomethyl-L-arginine (100/IM, n = 13, filled columns). 
Thereafter, the cells were incubated with 20/zM L-[3H]arginine for 1 h, 
and the concentration f L-[3H]ornithine in the supernatant (3H-Orn) 
was determined by HPLC analysis (**P < 0.01 vs. control, ++P < 0.01 
vs. LPS). 
L-[~H]ornithine formation was -60% higher in LPS-treated cells 
(Fig. 2). Unstimulated rat alveolar macrophages generated sim- 
ilar amounts of L-[3H]ornithine. In contrast o rabbit alveolar 
macrophages, L-[3H]ornithine formation was significantly re- 
duced after LPS-treatment (P < 0.01). Co-treatment of rat alve- 
olar macrophages with NG-monomethyl-L-arginine, on the 
other hand, resulted in an increase rather than decrease in 
L-[3H]ornithine formation (Fig. 2). 
Exogenously applied HOArg inhibited the formation of 
L-[3H]ornithine from k-[3H]arginine by LPS-treated rabbit alve- 
olar macrophages (Fig. 3a) with a half-maximally effective con- 
centration (IC50) of 15/~M. HOArg also reduced the arginase 
activity present in unstimulated rat alveolar macrophages in a 
concentration-dependent ma ner with an IC50 of 41/IM (Fig. 
3b). Interestingly, HOArg also inhibited the uptake of 
e-[3H]arginine by unstimulated rabbit alveolar macrophages 
(Fig. 3c). However, the half-maximally effective concentration 
(500/IM) for the inhibition of L-[3H]arginine uptake was much 
higher than that required for the inhibition of arginase. 
4. Discussion 
The present findings demonstrate hat induction of NO syn- 
thase in LPS-stimulated rat alveolar macrophages not only 
causes an increased production of NO (measured as NO2) and 
L-citrulline, but also markedly enhances the release of the NO 
synthase intermediate, HOArg, from these cells. The peak con- 
centration of HOArg in the conditioned medium was 37 ¢tM. 
At this concentration, arginase activity in these cells was re- 
duced by >- 50%. Moreover, L-[3H]ornithine formation by rab- 
bit alveolar macrophages was already significantly affected at 
concentrations as low as 1 /IM, supporting the notion 
that HOArg is the most potent arginase inhibitor known to 
date [4,5]. 
The hypothesis that HOArg may be an endogenous arginase 
inhibitor in alveolar macrophages i  supported by the N a- 
monomethyl-e-arginine-sensitive decrease in arginase activity 
in LPS-stimulated rat alveolar macrophages a  compared to 
LPS-stimulated rabbit alveolar macrophages, in which NO syn- 
thase activity (i.e. HOArg formation) was only marginally ele- 
vated. The finding that the formation of L-[3H]ornithine by 
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Fig. 3. Effects of HOArg on arginase activity (a,b) and on L-arginine transport (c). LPS-stimulated rabbit (a) or unstimulated rat (b) alveolar 
macrophages were incubated with L-[3H]arginine for 1 h in the absence or presence ofHOArg. L-[3H]Ornithine ([3H]-Orn) formation was determined 
by HPLC analysis and expressed as percentage of the mean control values. (c) Unstimulated rabbit alveolar macrophages were incubated with 
L-[3H]arginine ([3H]-Arg) for 5 min, and thereafter the cell-associated radioactivity was determined by liquid scintillation fl-counting (n = 3 8; 
*P < 0.01, **P < 0.01 vs. control, i.e. 100%). 
LPS-stimulated rat alveolar macrophages was actually in- 
creased in the presence of the NO synthase inhibitor as com- 
pared to control cells may reflect an enhanced expression of 
arginase [2]. 
In contrast to its potent effects on arginase activity, 
L-[3H]arginine transport in rabbit alveolar macrophages was 
inhibited by HOArg only at concentrations -> 100pM (ICs0 500 
pM). Similar findings (K~ 195 pM) have recently been reported 
for L-[3H]arginine transport in vascular smooth muscle cells [11] 
which like that in macrophages appears to be mediated by the 
y+ carrier system. A competition between e-arginine and 
HOArg for the same amino acid carrier could indeed explain 
why HOArg accumulates in the conditioned medium of LPS- 
treated alveolar macrophages. Moreover, the fact that no 
HOArg was detectable in cell lysates (cf. [6]) may indicate that 
any HOArg remaining in the cell is eventually metabolized to
NO and L-citrulline ither by NO synthase itself or other en- 
zymes, such as cytochrome P-450 monooxygenases [11,12], or 
is perhaps bound to arginase. On the basis of the present exper- 
iments, however, we cannot rule out a transport of HOArg via 
a neutral amino acid carrier system. 
The notion that a decrease in the extracellular level of 
L-arginine below a critical threshold may facilitate HOArg re- 
uptake and metabolism, on the other hand, is supported by the 
linear correlation (r -- 0.987) of the decrease in the concentra- 
tion of both HOArg and L-arginine in the conditioned medium 
of LPS-stimulated rat alveolar macrophages (n = 10, P < 0.01). 
A competition between HOArg and L-arginine for the same 
amino acid carrier may also be the reason for the apparent lack 
of effect of N°-monomethyl-L-arginine on the level of HOArg 
in the conditioned medium of LPS-stimulated rat alveolar mac- 
rophages. As shown in Fig. 1, the NO synthase inhibitor largely 
prevented the marked decrease in the extracellular concentra- 
tion of L-arginine following LPS treatment but, as judged by 
the level of NO2 and L-citrulline, left ~25% of the NO synthase 
activity intact. When considering the capacity of rat alveolar 
macrophages to generate HOArg (up to 37 pM) and the fact 
that NO synthase isthe only known source of HOArg, it is very 
likely that in this series of experiments he actual amount of 
HOArg produced by the cells following exposure to LPS has 
been underestimated on the basis of the extracellular HOArg 
level. Indeed, exposure of cultured vascular smooth muscle cells 
to interleukin-lfl or RAW 264.7 mouse macrophages to LPS 
also results in a significant production of HOArg which is 
abolished in the presence of NC'-nitro-L-arginine. The enhanced 
formation of HOArg (plus NO~ and L-citrulline) by these cells, 
however, is accompanied by a less pronounced decrease in the 
concentration of L-arginine in the conditioned medium (not 
below 130 pM) than that seen with the LPS-stimulated rat 
alveolar macrophages (Hecker et al., unpublished observa- 
tions). 
It is remarkable that up to 11% of the L-arginine consumed 
by the NO synthase in LPS-stimulated rat alveolar macroph- 
ages appeared as HOArg in the extracellular space. An accumu- 
lation of considerable amounts of HOArg (-> 17%) has also 
been described in the conditioned medium of LPS/IFN-y-stim- 
ulated murine mammary adenocarcioma cells (EMT-6, [6]), and 
small amounts of HOArg (-< 2%) were detected upon incuba- 
tion of the purified neuronal NO synthase with L-arginine [7]. 
These findings uggest that a significant portion of the HOArg 
which is generated in the course of the NO synthase reaction 
can be liberated from the active site of the enzyme and may thus 
escape further metabolism toNO and L-citrulline. This may be 
a consequence of the twofold higher K m value of the NO syn- 
thase for HOArg as compared to L-arginine [3,7] which favours 
its displacement from the active site by L-arginine. 
In summary, the present findings demonstrate hat LPS- 
stimulated murine macrophages release substantial mounts of 
HOArg which can affect arginase activity. Since exposure of 
macrophages to LPS may lead to a co-induction of NO syn- 
thase and arginase [2], the increased level of HOArg could limit 
arginase activity and direct L-arginine utilization towards an 
enhanced synthesis of NO. Moreover, by reducing the availa- 
bility of L-ornithine for polyamine synthesis, macrophage-de- 
rived HOArg may exert cytostatic effects, e.g. on tumor cells 
[6]. It remains to be determined, however, as to how HOArg 
leaves the cell which produces it. 
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